Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Eylea 40mg/ml solution for injection in a vial

Active Ingredient:
Company:  
ATC code: 
S01LA05
{info_black}
About Medicine
Audio and Video Guides to EYLEATo view or download a text version see the 'Risk Materials' tab

EYLEA BRVO Patient Guide - Audio Version
Your guide to Eylea - for the treatment of visual impairment due to macular oedema secondary to branch retinal vein occlusion(BRVO)

Reference: PP-EYL-GB-2100
EYLEA CNV Patient Guide - Audio Version
Your guide to Eylea - for the treatment of visual impairment due to myopic choroidal neovascularisation(myopic CNV)

Reference: PP-EYL-GB-2098
EYLEA CRVO Patient Guide - Audio Version
Your guide to Eylea - for the treatment of visual impairment due to macular oedema secondary to central retinal vein occlusion(CRVO)

Reference: PP-EYL-GB-2099
EYLEA DMO Patient Guide - Audio Version
Your guide to Eylea - for the treatment of visual impairment due to diabetic macular oedema(DMO)

Reference: PP-EYL-GB-2097
EYLEA WAMD Patient Guide - Audio Version
Your guide to Eylea - for the treatment of neovascular (wet) age-related macular degeneration(AMD)

Reference: PP-EYL-GB-2096
EYLEA Prescriber Guide
Intravitreal injection procedure video intended for Healthcare Professionals


Bayer plc
Company image
Address
400 South Oak Way, Reading, Berkshire, RG2 6AD
Telephone
+44 (0)118 206 3000
Medical Information e-mail
[email protected]